Showing 2361-2370 of 3134 results for "".
- NYC Dermatologist Dr. Doris Day Joins Nufabrx’s Ad Boardhttps://modernaesthetics.com/news/nyc-dermatologist-dr-doris-day-joins-nufabrxs-ad-board/2472988/New York City dermatologist Doris Day, MD is the newest member of Nufabrx’s advisory board. Nufabrx is an advanced textiles company that has developed a proprietary biomaterial platform that embeds active ingredient
- New CEO at NuFACEhttps://modernaesthetics.com/news/new-ceo-at-nuface/2472984/Michael Larrain is the new Chief Executive Officer at NuFACE. Tera Peterson, former CEO, will remain at the company as Co-Founder, Chairman of the Board and Chief Creative Officer. Larrain was CEO at PCA Sk
- Estée Lauder and Atropos Therapeutics Team Up to Discover Senomodulatorshttps://modernaesthetics.com/news/estee-lauder-and-atropos-therapeutics-team-up-to-discover-senomodulators/2472980/The Estée Lauder Companies and Atropos Therapeutics are joining forces to discover botanical senomodulators or senescence-modulating chemicals. Atropos Therapeutics Inc. has a proprietary platform to identify a
- BTL Files New Complaint Against Allergan, Affiliates in Patent Fighthttps://modernaesthetics.com/news/btl-files-new-complaint-against-allergan-affiliates-in-patent-fight/2472976/BTL Industries, Inc. has filed a complaint with the United States International Trade Commission (ITC), asking the Commission to prevent Allergan Limited, Allergan, Inc., Allergan USA Inc., Zeltiq Aesthetics, Inc., Zeltiq Ireland Unlimited Company, and Zimmer MedizinSysteme GmbH, G
- NYC Plastic Surgeon Dr. Sachin Shridharani Joins Soliton’s Scientific Advisory Boardhttps://modernaesthetics.com/news/sachin-shridharani-md-joins-solitons-scientific-advisory-board/2472973/Sachin Shridharani, MD has joined Soliton, Inc’s Scientific Advisory Board. Soliton, Inc. recently filed for 510(k) premarket clearance with the U.S. Food and Drug Administration (FDA) of its second-generation Rapid Acoustic Pulse (RAP) device for the reduction in the appearance o
- Amber Edwards Named Alastin Skincare’s New Chief Commercial Officerhttps://modernaesthetics.com/news/amber-edwards-named-alastin-skincares-new-chief-commercial-officer/2472971/Amber Edwards is Alastin Skincare’s new Chief Commercial Officer, effective July 31, 2020 Ms. Edwards most recently served as President of North America for Sinclair Pharma. Prior to Sinclair, she was at Allergan, Inc. where she was the Vice President of International S
- Alastin Skincare Scores Another New Patenthttps://modernaesthetics.com/news/alastin-skincare-scores-another-new-patent/2472970/Alastin Skincare, Inc. received a fourth U.S. Patent from the United States Patent and Trademark Office. The new patent, which incorporates TriHex Technology, is directed to a topical composition for alleviating bruising caused by a cosmetic procedure—INhance Post-Injection Serum
- Restylane Kysse Shows Positive Kissability Satisfaction in Phase 4 Studyhttps://modernaesthetics.com/news/restylane-kysse-shows-positive-kissability-satisfaction-in-phase-4-study/2472966/In a first-of-its-kind phase IV, Kissability study for an injectable hyaluronic acid (HA) lip filler, researchers evaluated subject satisfaction as well as partner satisfaction following treatment with Restylane Kysse. Many consumers report they often keep their lip treatments a
- New from Cutera: Get to Know Fraxis PROhttps://modernaesthetics.com/news/new-from-cutera-get-to-know-fraxis-pro/2472965/Cutera, Inc. is launching Fraxis PRO progressive dermal remodeling technology. Fraxis PRO combines fractional CO2 for skin resurfacing and radiofrequency microneedling for dermal remodeling in a single device. Fraxis PRO treats: Fine Lines Wr
- Allergan Donates $300K to Bridge the Gender Gap in STEMhttps://modernaesthetics.com/news/allergan-donates-300k-to-bridge-the-gender-gap-in-stem/2472964/Allergan has pledged $300K to support STEM Education through their partnership with Girls Inc. In addition to the donation, Allergan is also offering mentoring initiatives and resources to educate and empower future female leaders interest